A Comparative Dissolution Kinetics Test for Omeprazole-Containing Medicines, Reproducing Secretory and Motor-Evacuatory Impairments the Stomach of Patients with Acid-Dependent Diseases


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

A comparative dissolution kinetics test was used to study the release (dissolution kinetics) of an original and 10 generic formulations of omeprazole from different manufacturers in a medium simulating the moderately acidic conditions in the stomach typical of the state of medication-induced suppression of acidity; tests were also performed in a model of pathological duodenogastric reflux. HPLC was used to measure omeprazole concentrations in aliquots collected at 4, 10, 15, 20, 30, 45, and 60 min in solution with pH 7.0 ± 0.05 after 2 h of exposure at pH 1.2 ± 0.05 or 4.0 ± 0.05. The duration of action of pathological duodenogastric reflux on the therapeutic formulations of omeprazole was 4 min. Not all the study formulations could be completely recognized as equivalents to the original formulation in the in vitro test conditions.

Sobre autores

G. Vasilenko

Scientific Center for Expert Evaluation of Medical Products, Ministry of Health of the Russian Federation

Email: chem@folium.ru
Rússia, Building 2, 8 Petrovskii Boulevard, Moscow, 127051

L. Krasnykh

Scientific Center for Expert Evaluation of Medical Products, Ministry of Health of the Russian Federation

Email: chem@folium.ru
Rússia, Building 2, 8 Petrovskii Boulevard, Moscow, 127051

S. Serebrova

Scientific Center for Expert Evaluation of Medical Products, Ministry of Health of the Russian Federation; I. M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation (Sechenov University)

Email: chem@folium.ru
Rússia, Building 2, 8 Petrovskii Boulevard, Moscow, 127051; Building 2, Moscow

A. Prokof’ev

Scientific Center for Expert Evaluation of Medical Products, Ministry of Health of the Russian Federation; I. M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation (Sechenov University)

Email: chem@folium.ru
Rússia, Building 2, 8 Petrovskii Boulevard, Moscow, 127051; Building 2, Moscow

G. Ramenskaya

Scientific Center for Expert Evaluation of Medical Products, Ministry of Health of the Russian Federation; I. M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation (Sechenov University)

Email: chem@folium.ru
Rússia, Building 2, 8 Petrovskii Boulevard, Moscow, 127051; Building 2, Moscow

E. Smolyarchuk

I. M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation (Sechenov University)

Email: chem@folium.ru
Rússia, Building 2, Moscow

D. Kurguzova

I. M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation (Sechenov University)

Email: chem@folium.ru
Rússia, Building 2, Moscow

A. Barkov

I. M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation (Sechenov University)

Email: chem@folium.ru
Rússia, Building 2, Moscow


Declaração de direitos autorais © Springer Science+Business Media, LLC, part of Springer Nature, 2017

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies